デフォルト表紙
市場調査レポート
商品コード
1085380

心臓補綴デバイスの世界市場:製品タイプ別(心臓弁、ペースメーカー)、エンドユーザー別、地域別-規模、シェア、展望、機会分析(2022年~2028年)

Cardiac Prosthetic Devices Market, By Product Type (Heart Valves, Pacemaker ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

出版日: | 発行: Coherent Market Insights | ページ情報: 英文 165 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
心臓補綴デバイスの世界市場:製品タイプ別(心臓弁、ペースメーカー)、エンドユーザー別、地域別-規模、シェア、展望、機会分析(2022年~2028年)
出版日: 2022年05月31日
発行: Coherent Market Insights
ページ情報: 英文 165 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

高血圧の有病率の増加は、予測期間中の世界の心臓補綴デバイス市場の成長を促進すると予想されます。さらに、研究や製品発表の増加も市場の成長を後押しすると予想されます。

当レポートでは、世界の心臓補綴デバイス市場について調査しており、市場展望、市場力学、市場分析、競合情勢など、包括的な情報を提供しています。

目次

第1章 調査目的・前提条件

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
    • 市場の内訳:製品タイプ別
    • 市場の内訳:エンドユーザー別
    • 市場の内訳:国別
    • コヒーレントオポチュニティマップ(COM)

第3章 市場力学、規制、および動向分析

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 影響分析
  • 主なハイライト
  • 製品発売
  • PEST分析
  • 技術の進歩
  • 規制シナリオ
  • 合併と買収

第4章 世界の心臓補綴デバイス市場:製品タイプ別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 心臓弁
  • ペースメーカー

第5章 世界の心臓補綴デバイス市場:エンドユーザー別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 病院
  • 専門センター
  • その他

第6章 世界の心臓補綴デバイス市場:地域別(100万米ドル)(2017年~2028年)

  • イントロダクション
  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第7章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Abiomed, Inc.
    • AtriCure, Inc.
    • Boston Scientific Corporation
    • Edward Lifesciences Corporation
    • BIOTRONIK
    • Braile Biomedica
    • CryoLife, Inc.
    • Labcor Laboratrios
    • Lepu Medical
    • Lifetech Scientific
    • LivaNova
    • Medtronic plc.
    • Meril Life Sciences
    • MicroPort Scientific
    • Shree Pacetronix
    • TTK Healthcare
    • Venus Medtech
    • Vitatron

第8章 セクション

目次
Product Code: CMI3862

Cardiac Prosthetic Devices comprises of prosthetic heart valves such as mechanical heart valve and tissue heart valve along with annuloplasty rings, pacemaker leads, defibrillator leads, tissue patches, ventricular assist devices, and artificial hearts. These are used to replace damaged or diseased natural valves of the heart. Increasing prevalence of hypertension is expected to propel growth of the global cardiac prosthetic devices market over the forecast period. Furthermore, increasing research and product launches is also anticipated to assist the growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the Global Cardiac Prosthetic Devices market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Cardiac Prosthetic Devices market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Abbott Laboratories, Abiomed, Inc., AtriCure, Inc., Boston Scientific Corporation, Edward Lifesciences Corporation BIOTRONIK, Braile Biomedica, CryoLife, Inc., Labcor Laboratrios, Lepu Medical, Lifetech Scientific, LivaNova, MEDICO, Medtronic plc, Meril Life Sciences, MicroPort Scientific, Shree Pacetronix, TTK Healthcare, Venus Medtech, and Vitatron.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Cardiac Prosthetic Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Cardiac Prosthetic Devices market

Detailed Segmentation:

  • Global Cardiac Prosthetic Devices Market, By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
  • Global Cardiac Prosthetic Devices Market, By End User:
    • Hospital
    • Specialty Centers
    • Others
  • Global Cardiac Prosthetic Devices Market, By Region:
  • North America
    • By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
    • By End User
    • Hospital
    • Specialty Centers
    • Others
    • By Country
    • U.S.
    • Canada
  • Latin America
    • By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
    • By End User
    • Hospital
    • Specialty Centers
    • Others
    • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
    • By End User
    • Hospital
    • Specialty Centers
    • Others
    • By Country
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
    • By End User
    • Hospital
    • Specialty Centers
    • Others
    • By Country
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
    • By End User
    • Hospital
    • Specialty Centers
    • Others
    • By Country
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • By Product Type:
    • Heart Valves
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
    • Pacemaker
    • Implantable Pacemaker
    • External Pacemaker
    • By End User
    • Hospital
    • Specialty Centers
    • Others
    • By Country
    • North Africa
    • Central Africa
    • South Africa
  • Company Profiles
  • Abbott Laboratories *
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Abiomed, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • Edward Lifesciences Corporation
  • BIOTRONIK
  • Braile Biomedica
  • CryoLife, Inc.
  • Labcor Laboratrios
  • Lepu Medical
  • Lifetech Scientific
  • LivaNova
  • Medtronic plc.
  • Meril Life Sciences
  • MicroPort Scientific
  • Shree Pacetronix
  • TTK Healthcare
  • Venus Medtech
  • Vitatron

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product launch
  • PEST Analysis
  • Technological Advancements
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Cardiac Prosthetic Devices Market, By Product Type, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Heart Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Mechanical Heart Valves
    • Tissue Heart Valves
    • Transcatheter Heart Valves
  • Pacemaker
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
    • Implantable Pacemaker
    • External Pacemaker

5. Global Cardiac Prosthetic Devices Market, By End User, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Specialty Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Cardiac Prosthetic Devices Market, By Region, 2017 - 2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
  • North America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Abiomed, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AtriCure, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Boston Scientific Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Edward Lifesciences Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • BIOTRONIK
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Braile Biomedica
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • CryoLife, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Labcor Laboratrios
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lepu Medical
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lifetech Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • LivaNova
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Medtronic plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Meril Life Sciences
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • MicroPort Scientific
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Shree Pacetronix
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • TTK Healthcare
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Venus Medtech
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Vitatron
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact